Imagine a CEO of a pharmaceutical company facing a critical decision. They are developing a new drug with potentially life-saving benefits, but early clinical trials show troubling side effects. The company is facing immense pressure from investors and the public to release the drug. To proceed, the CEO could choose to leverage plausible deniability.
Here's how this might play out:
1. Delegating Responsibility: The CEO could delegate the decision to a trusted subordinate, such as the head of research and development. They could emphasize the potential benefits of the drug and the urgency of bringing it to market. They might say, "I trust your judgment, but ultimately, the decision rests with you." This creates a layer of separation between the CEO and the potentially risky decision.
2. Limiting Information Flow: The CEO might limit the amount of information they receive about the potential risks. They might focus on positive ....
Log in to view the answer